Signia Therapeutics
Breakthrough Solutions for Respiratory Infections and Pathologies.
Signia Therapeutics has raised €1.7M across 1 funding round from 1 investor, most recently a round in Jan 2022. Based in Villeurbanne, France; active in Healthtech. Data as of 28 Oct 2026.
Villeurbanne, Francesigniatherapeutics.com/en ↗
Total raised
€1.7M
€1,700,000
Funding rounds
1
Investors
1
distinct backers
Active since
2022-01
latest 2022-01
Funding by year
EUR raised per yearSignia Therapeutics — funding by year — interactive chart.
Data table
| Signia Therapeutics — funding by year | |
|---|---|
| 2022 | €1.7M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-01-06 | Other | €1.7M | Bpifrance | View deal → |
Investors
1Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData